Innovation translation at the AO and its AO Innovation Translation Center (AO ITC) encompasses the conception, strategic evaluation, and development of clinical solutions in collaboration with industrial partners. It includes proof-of-concept work with innovators, valorization of new technologies and techniques and clinical evidence creation to prove the added value of new solutions. Strategic investments in intellectual property, technology, and companies are also part of AO ITC's mandate.
At the center of all innovation is myAO's global network of surgeons and other healthcare providers who contribute ideas and expert guidance at all stages of development.
AO ITC: The innovative core of the AO's global network
From idea to market: Introducing the newly-CE marked Biphasic Plate
Fast, robust healing of long-bone fractures through confident weight bearing is the goal of the Biphasic Plating concept, a new solution devised by the AO Research Institute Davos (ARI) in Switzerland, Queensland University of Technology (QUT) in Brisbane, Australia. Due to the development incubator funding from the AO Innovation Translation Center (AO ITC), the development phase of the distal femur version started in 2018 and today the plate is CE mark approved, and in first-series production in preparation for clinical application in 2021 in Europe. [Learn more]
Watch the webinar about the Biphasic Plate and how to transform an idea into a CE-marked device
Biphasic Plating - In vivo study of a novel fixation concept to enhance mechanobiological fracture healing Injury (2020-08-01) Ladina Hofmann-Fliri, Devakara R Epari, Ronald Schwyn, Stephan Zeiter, Markus Windolf Read more
Biphasic plating improves the mechanical performance of locked plating for distal femur fractures, J Biomech (Jan 22) Devakara R Epari, Roshan Gurung, Ladina Hofmann-Fliri, Ronald Schwyn, Michael Schuetz, Markus Windolf Read more
